Bay Street News, 2020

BELTSVILLE, Md., May 29, 2020 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and […]

RESEARCH TRIANGLE PARK, N.C., May 29, 2020 (GLOBE NEWSWIRE) — Charles & Colvard, Ltd. (Nasdaq: CTHR), (the “Company”), the original […]

– First Presentation of Clinical Data for CX-2029, a Probody Drug Conjugate, Directed Against CD71: A Previously Undruggable Target –– Data […]

Median Duration of Response Not Reached at 18.7 Months of Median Study Follow Up36.4% Overall Response Rate (ORR) MaintainedSAN CARLOS, […]

HOUSTON, May 29, 2020 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense […]

– Shares of combined company to commence trading on Nasdaq Global Market under the symbol “LRMR” on May 29, 2020– […]

– Additional follow-up in Phase 3 ASPEN trial continued to show clinically meaningful safety and tolerability advantages for zanubrutinib compared […]

BASKING RIDGE, N.J., May 29, 2020 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that […]

SOUTH SAN FRANCISCO, Calif., May 29, 2020 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused […]

VANCOUVER, British Columbia, May 29, 2020 (GLOBE NEWSWIRE) — Candente Gold Corp. (TSXV:CDG) (“Candente Gold” and/or the “Company”) is pleased […]